MYX mayne pharma group limited

Lazard Portfolio comments in fin review, page-16

  1. 309 Posts.
    lightbulb Created with Sketch. 304
    Well, down 20% from the last time I posted. First a surge on no news, now a decline on no news.
    I can’t work out this stock. I read your posts and admire your optimism. I pray that these products turn this around.
    I wish I had ever seen Myx. Almost the worst outcome I’ve ever had in my life of trading. Definitely the most financially costly mistake I’ve ever made. Management should be purged. That would probably be the only way to turn this around. Still wondering why Mithra chose MYX. Struggling to get Nuvaring thru FDA approval. With their 500 scientists they can’t persuade FDA? Shows how incompetent management really are.
    Maybe the. AGM will answer some questions.
    cheers all.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.07
Change
0.050(1.00%)
Mkt cap ! $411.9M
Open High Low Value Volume
$5.00 $5.14 $4.94 $712.4K 141.2K

Buyers (Bids)

No. Vol. Price($)
1 1059 $5.07
 

Sellers (Offers)

Price($) Vol. No.
$5.13 1000 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.